213 related articles for article (PubMed ID: 29338495)
1. Clinical challenges in de novo pediatric acute myeloid leukemia.
Klein K; de Haas V; Kaspers GJL
Expert Rev Anticancer Ther; 2018 Mar; 18(3):277-293. PubMed ID: 29338495
[TBL] [Abstract][Full Text] [Related]
2. [Acute leukemia in adults].
Eigendorff E; Hochhaus A
Pathologe; 2015 Sep; 36(5):503-17; quiz 518-9. PubMed ID: 26314268
[TBL] [Abstract][Full Text] [Related]
3. Overview of therapy and strategies for optimizing outcomes in de novo pediatric acute myeloid leukemia.
Faulk K; Gore L; Cooper T
Paediatr Drugs; 2014 Jun; 16(3):213-27. PubMed ID: 24639021
[TBL] [Abstract][Full Text] [Related]
4. Current Management of Childhood Acute Myeloid Leukemia.
Rubnitz JE
Paediatr Drugs; 2017 Feb; 19(1):1-10. PubMed ID: 27785777
[TBL] [Abstract][Full Text] [Related]
5. Pediatric acute myeloid leukemia: Insight into genetic landscape and novel targeted approaches.
Tosic N; Marjanovic I; Lazic J
Biochem Pharmacol; 2023 Sep; 215():115705. PubMed ID: 37532055
[TBL] [Abstract][Full Text] [Related]
6. Cell cycle inhibitors for the treatment of acute myeloid leukemia: a review of phase 2 & 3 clinical trials.
Jammal N; Rausch CR; Kadia TM; Pemmaraju N
Expert Opin Emerg Drugs; 2020 Dec; 25(4):491-499. PubMed ID: 33161749
[No Abstract] [Full Text] [Related]
7. [Risk-adapted therapy of acute myeloid leukemia].
Hiddemann W; Spiekermann K; Braess J; Feuring-Buske M; Buske C; Büchner T
Internist (Berl); 2006 Jun; 47 Suppl 1():S33-9. PubMed ID: 16773364
[TBL] [Abstract][Full Text] [Related]
8. Identifying effective drug combinations for patients with acute myeloid leukemia.
Yilmaz M; Kadia T; Ravandi F
Expert Rev Anticancer Ther; 2020 Jul; 20(7):591-601. PubMed ID: 32552126
[TBL] [Abstract][Full Text] [Related]
9. Pediatric acute myeloid leukemia: updates on biology, risk stratification, and therapy.
Elgarten CW; Aplenc R
Curr Opin Pediatr; 2020 Feb; 32(1):57-66. PubMed ID: 31815781
[TBL] [Abstract][Full Text] [Related]
10. The blind men and the AML elephant: can we feel the progress?
Tauro S
Blood Cancer J; 2016 May; 6(5):e424. PubMed ID: 27176800
[TBL] [Abstract][Full Text] [Related]
11. Frontline treatment of acute myeloid leukemia in adults.
Tamamyan G; Kadia T; Ravandi F; Borthakur G; Cortes J; Jabbour E; Daver N; Ohanian M; Kantarjian H; Konopleva M
Crit Rev Oncol Hematol; 2017 Feb; 110():20-34. PubMed ID: 28109402
[TBL] [Abstract][Full Text] [Related]
12. Improved treatment results in high-risk pediatric acute myeloid leukemia patients after intensification with high-dose cytarabine and mitoxantrone: results of Study Acute Myeloid Leukemia-Berlin-Frankfurt-Münster 93.
Creutzig U; Ritter J; Zimmermann M; Reinhardt D; Hermann J; Berthold F; Henze G; Jürgens H; Kabisch H; Havers W; Reiter A; Kluba U; Niggli F; Gadner H
J Clin Oncol; 2001 May; 19(10):2705-13. PubMed ID: 11352963
[TBL] [Abstract][Full Text] [Related]
13. Treatment of childhood acute myeloid leukemia.
ter Bals E; Kaspers GJ
Expert Rev Anticancer Ther; 2005 Oct; 5(5):917-29. PubMed ID: 16221060
[TBL] [Abstract][Full Text] [Related]
14. Emerging strategies for the treatment of older patients with acute myeloid leukemia.
Sanz MA; Iacoboni G; Montesinos P; Venditti A
Ann Hematol; 2016 Oct; 95(10):1583-93. PubMed ID: 27118541
[TBL] [Abstract][Full Text] [Related]
15. [Strategies to improve therapeutic efficacy in childhood acute myeloid leukemia].
Zhu XF
Zhongguo Dang Dai Er Ke Za Zhi; 2014 Feb; 16(2):108-10. PubMed ID: 24568899
[TBL] [Abstract][Full Text] [Related]
16. Decreased relapsed rate and treatment-related mortality contribute to improved outcomes for pediatric acute myeloid leukemia in successive clinical trials.
Alexander TB; Wang L; Inaba H; Triplett BM; Pounds S; Ribeiro RC; Pui CH; Rubnitz JE
Cancer; 2017 Oct; 123(19):3791-3798. PubMed ID: 28556917
[TBL] [Abstract][Full Text] [Related]
17. International randomized phase III study of elacytarabine versus investigator choice in patients with relapsed/refractory acute myeloid leukemia.
Roboz GJ; Rosenblat T; Arellano M; Gobbi M; Altman JK; Montesinos P; O'Connell C; Solomon SR; Pigneux A; Vey N; Hills R; Jacobsen TF; Gianella-Borradori A; Foss Ø; Vetrhusand S; Giles FJ
J Clin Oncol; 2014 Jun; 32(18):1919-26. PubMed ID: 24841975
[TBL] [Abstract][Full Text] [Related]
18. Acute myeloid leukemia in children: Current status and future directions.
Taga T; Tomizawa D; Takahashi H; Adachi S
Pediatr Int; 2016 Feb; 58(2):71-80. PubMed ID: 26645706
[TBL] [Abstract][Full Text] [Related]
19. The emergence of acid ceramidase as a therapeutic target for acute myeloid leukemia.
Tan SF; Pearson JM; Feith DJ; Loughran TP
Expert Opin Ther Targets; 2017 Jun; 21(6):583-590. PubMed ID: 28434262
[TBL] [Abstract][Full Text] [Related]
20. Treatment of Elderly Patients With Acute Myeloid Leukemia.
Thomas X; Le Jeune C
Curr Treat Options Oncol; 2017 Jan; 18(1):2. PubMed ID: 28144802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
